Yield Theory

John Boozman · BSX

John Boozman's BSX trades

Every Boston Scientific Corporation transaction John Boozman reported to the Senate eFD in 2025 and 2026, from the original periodic transaction reports.
Transactions
3
Buys / sells
1 / 2
Disclosed range
$3K – $45K
Last filed
2026-07-13

BSX transactions reported by John Boozman

3 of 3 rows
TypeOwner
Boston Scientific Corporation Common Stock
BSX
SaleJoint$1,001 - $15,0002026-07-13
#c52854ed-a778-483a-883c-0ba2bba17877
Boston Scientific Corp
BSX
SaleJoint$1,001 - $15,0002026-01-13
#d3daa40b-123d-4451-9974-02bf5a96d8da
Boston Scientific Corp
BSX
PurchaseJoint$1,001 - $15,0002025-03-06
#6cf4a78e-92f0-4201-bf73-e9b02cd8f9ef

A row is a disclosure, not an execution record: the filing reports a date, a bracket, and the reported owner, but not the price, share count, or reason. Compare the trade date with the filing date to see how long the transaction stayed private.

Members-only research

What members are reading this month

The thesis, the numbers behind it, and what would break it. Full access is $15 a month.

Read the full research

John Boozman and BSX — questions

Did John Boozman buy or sell BSX?

Senate eFD filings for 2025 and 2026 show 1 purchase and 2 sales of Boston Scientific Corporation (BSX) reported by John Boozman, between 2025-02-13 and 2026-06-04. Reported owner: Joint.

How much BSX did John Boozman trade?

Filings disclose brackets, not exact values. Summing the low and high ends of each bracket gives $3K – $45K across 3 transactions. Yield Theory does not estimate share counts, prices, or gains from these ranges.

When was the last BSX filing by John Boozman?

The most recent periodic transaction report containing a BSX row was filed on 2026-07-13. New filings appear in the Senate eFD index and are picked up when the dataset is refreshed.

Yield Theory is not affiliated with any elected official or with Boston Scientific Corporation. Rows are parsed from public Senate eFD periodic transaction reports; amounts are reported brackets and filings can be amended. This page is educational and is not investment advice.

Don’t copy the filing. Read the thesis.

John Boozman BSX disclosures are delayed, ranged, and often a spouse. Members get the monthly call that treats those rows as one input, then names catalysts, risks, and what would change the view. $15/month or $150/year.

$15/mo or $150/yr · cancel future renewals anytime · sources included